BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 390681)

  • 21. [Preliminary experience with the investigation of cellular immunity by the test of inhibition of leucocyte adherence in psoriasis vulgaris (author's transl)].
    Vasícková M; Fadrhoncová A; Jandová A; Heyberger K; Coupek J; Sanitrák J
    Sb Lek; 1979; 81(11-12):341-3. PubMed ID: 390685
    [No Abstract]   [Full Text] [Related]  

  • 22. [Value of LAI test in immunodiagnosis of gynecologic tumors (author's transl)].
    Trnka V; Heyberger K; Jandová A
    Bratisl Lek Listy; 1979 Sep; 72(3):280-3. PubMed ID: 389362
    [No Abstract]   [Full Text] [Related]  

  • 23. [The LDH virus and changes in cellular immunity in schizophrenics and their relatives].
    Dvoráková M; Zvolský P; Jandová A
    Sb Lek; 1990 Oct; 92(10):305-10. PubMed ID: 2263869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Further experience with the test of inhibition of leucocyte adherence (LAI) in the diagnosis of melanoblastomas of the choroid (author's transl)].
    Kubát Z; Sachsová D; Jandová A; Heyberger K; Andrysek O
    Sb Lek; 1979; 81(11-12):333-6. PubMed ID: 390683
    [No Abstract]   [Full Text] [Related]  

  • 25. [Investigation of the specific immunological reaction in the course of herpes zoster by means of the LAI test (author's transl)].
    Vasícková M; Fadrhoncová A; Jandová A; Heyberger K; Doutlík S; Vacek Z; Coupek J; Sanitrák J
    Sb Lek; 1979; 81(11-12):344-6. PubMed ID: 390686
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical uses of the leucocyte adherence inhibition test in patients with laryngeal carcinoma (author's transl)].
    Síbl O; Holán V
    Cas Lek Cesk; 1979 Jul; 118(27):837-40. PubMed ID: 387249
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
    Varga A; Stosiek P; Kasper M
    Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence and other characteristics of the lactate dehydrogenase-elevating virus (LDH-virus).
    Riley V
    Prog Med Virol; 1974; 18(0):198-213. PubMed ID: 4608417
    [No Abstract]   [Full Text] [Related]  

  • 29. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
    Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
    Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes.
    Stevenson MM; Rees JC; Meltzer MS
    J Immunol; 1980 Jun; 124(6):2892-9. PubMed ID: 7373055
    [No Abstract]   [Full Text] [Related]  

  • 31. [Using cell-mediaed immunity for the diagnosis of toxoplasmosis and trichomoniasis (author's transl)].
    Heyberger K; Jandová A; Mejsnarová B; Novotná J; Trnka V
    Sb Lek; 1979; 81(11-12):347-8. PubMed ID: 390687
    [No Abstract]   [Full Text] [Related]  

  • 32. The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus.
    Isakov N; Feldman M; Segal S
    J Immunol; 1982 Feb; 128(2):969-75. PubMed ID: 7198665
    [No Abstract]   [Full Text] [Related]  

  • 33. [Leucocyte adherence inhibition with cryopresfrved mononuclear cells and autologous tumor extract (author's transl)].
    Onji M; Yamashita Y; Minakami Y; Ohta Y
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jul; 77(7):1122. PubMed ID: 6997583
    [No Abstract]   [Full Text] [Related]  

  • 34. Summary and future prospects of leukocyte adherence inhibition.
    Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):660-2. PubMed ID: 367591
    [No Abstract]   [Full Text] [Related]  

  • 35. Current status of leukocyte adherence inhibition.
    Howell JH
    Cancer Res; 1979 Feb; 39(2 Pt 2):556-7. PubMed ID: 367581
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic diagnosis of malignant neoplasms. I].
    Shuster J; Thomson DM; Fuks A; Gold P
    Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reaction of leukocyte adherence inhibition and its use in oncology].
    Osinov SG; Eremeev VS; Bergol'ts VM
    Vopr Onkol; 1979; 25(10):74-80. PubMed ID: 388861
    [No Abstract]   [Full Text] [Related]  

  • 39. Demonstration and evaluation of the leukocyte adherence inhibition assay.
    Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):624. PubMed ID: 367587
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dependence of leukocyte migration inhibition on the progress and activity of gynecological tumours (author's transl)].
    Tosner J; Fixa B
    Cesk Gynekol; 1979 Sep; 44(8):587-91. PubMed ID: 498305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.